• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺胺类药物过敏:事实与虚构。

Sulfonamide Hypersensitivity: Fact and Fiction.

机构信息

Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex.

Division of Clinical Pharmacology and Toxicology, Department of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2116-2123. doi: 10.1016/j.jaip.2019.05.034.

DOI:10.1016/j.jaip.2019.05.034
PMID:31495421
Abstract

Sulfonamide antimicrobials are commonly reported as causing drug allergy and have been implicated in a variety of hypersensitivity reactions including immediate IgE-mediated reactions, benign T-cell-mediated rashes, and severe cutaneous adverse reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms. Cross-reactivity is unlikely between sulfonamide antimicrobials and sulfonamide non-antimicrobials. In patients who develop reactions to a sulfonamide non-antimicrobial, there is no evidence to suggest that sulfonamide antimicrobials and other sulfonamide non-antimicrobials would cross-react. Although immediate skin testing can be performed in patients with histories of immediate reactions, they are infrequently positive and wane over time. Delayed skin testing including patch tests to sulfonamides is rarely positive. Drug challenges are a useful tool for patients with both immediate and delayed reactions to sulfonamides. The role of sulfamethoxazole desensitization is controversial as rates of hypersensitivity reactions are similar between desensitization and drug challenge.

摘要

磺胺类抗菌药物通常被报道为引起药物过敏,并与各种过敏反应有关,包括立即 IgE 介导的反应、良性 T 细胞介导的皮疹以及严重的皮肤不良反应,如史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症和药物反应伴嗜酸性粒细胞增多和全身症状。磺胺类抗菌药物与磺胺类非抗菌药物之间不太可能发生交叉反应。在对磺胺类非抗菌药物产生反应的患者中,没有证据表明磺胺类抗菌药物和其他磺胺类非抗菌药物会发生交叉反应。尽管对于有立即反应史的患者可以进行即时皮肤测试,但它们通常呈阴性,并且随着时间的推移而减弱。磺胺类药物延迟皮肤测试(包括斑贴试验)很少呈阳性。药物挑战是对磺胺类药物有立即和延迟反应的患者的有用工具。磺胺甲恶唑脱敏的作用存在争议,因为脱敏和药物挑战之间的过敏反应发生率相似。

相似文献

1
Sulfonamide Hypersensitivity: Fact and Fiction.磺胺类药物过敏:事实与虚构。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2116-2123. doi: 10.1016/j.jaip.2019.05.034.
2
Sulfonamide Hypersensitivity.磺胺类药物过敏。
Clin Rev Allergy Immunol. 2022 Jun;62(3):400-412. doi: 10.1007/s12016-021-08872-3. Epub 2021 Jul 1.
3
Sulfonamide hypersensitivity.磺胺类药物过敏
Immunol Allergy Clin North Am. 2004 Aug;24(3):477-90, vii. doi: 10.1016/j.iac.2004.03.011.
4
Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy.对磺胺类药物过敏的患者是否应禁用塞来昔布?重新审视“磺胺”过敏的含义。
Drug Saf. 2001;24(4):239-47. doi: 10.2165/00002018-200124040-00001.
5
Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.塞来昔布在磺胺类药物过敏个体中的安全性:一项试点研究。
Drug Saf. 2003;26(3):187-95. doi: 10.2165/00002018-200326030-00004.
6
Sulfonamide Drug Allergy.磺胺类药物过敏。
Curr Allergy Asthma Rep. 2018 Jun 6;18(7):38. doi: 10.1007/s11882-018-0791-9.
7
Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.儿童和成人的抗生素过敏:从临床症状到皮肤点刺试验诊断。
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):3-12. doi: 10.1016/j.jaip.2013.11.006.
8
New concepts in the management of adverse drug reactions.药物不良反应管理的新概念。
Allergy Asthma Proc. 2007 Sep-Oct;28(5):517-24. doi: 10.2500/aap2007.28.3030.
9
Approach to the patient with drug allergy.药物过敏患者的处理方法。
Med Clin North Am. 2010 Jul;94(4):665-79, xv. doi: 10.1016/j.mcna.2010.03.006.
10
Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?处理HIV感染中对磺胺类药物及其他药物的药物反应:脱敏而非再次激发?
Pharm World Sci. 1998 Dec;20(6):253-7. doi: 10.1023/a:1008617019897.

引用本文的文献

1
Evaluation of Adverse Events Associated with the Sulfamethoxazole/Trimethoprim Combination Drug.与磺胺甲恶唑/甲氧苄啶复方药物相关的不良事件评估。
J Clin Med. 2025 Jul 8;14(14):4819. doi: 10.3390/jcm14144819.
2
An Atypical Manifestation of Cellulitis Induced by Proteus mirabilis.奇异变形杆菌引起的蜂窝织炎的非典型表现。
Cureus. 2025 Jun 2;17(6):e85249. doi: 10.7759/cureus.85249. eCollection 2025 Jun.
3
Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta-analysis with active comparator disproportionality analysis.
磺胺甲恶唑-甲氧苄啶用于门诊治疗细菌感染的安全性:一项采用活性对照药物不均衡性分析的系统评价和荟萃分析
Br J Clin Pharmacol. 2025 Jun;91(6):1632-1648. doi: 10.1111/bcp.70051.
4
Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta-analysis with active comparator disproportionality analysis.磺胺甲恶唑-甲氧苄啶用于门诊治疗细菌感染的安全性:一项采用活性对照品不成比例分析的系统评价和荟萃分析。
Br J Clin Pharmacol. 2025 Jun;91(6):1632-1648. doi: 10.1002/bcp.70051. Epub 2025 Mar 24.
5
The role of acetazolamide in critical care and emergency medicine.乙酰唑胺在重症监护和急诊医学中的作用。
J Geriatr Cardiol. 2024 Nov 28;21(11):1085-1095. doi: 10.26599/1671-5411.2024.11.005.
6
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - A retrospective matched cohort study.磺胺类药物过敏标签与实体器官移植受者机会性感染的风险:一项回顾性匹配队列研究。
Transpl Infect Dis. 2024 Oct;26(5):e14355. doi: 10.1111/tid.14355. Epub 2024 Aug 13.
7
Diuretic Treatment in Heart Failure: A Practical Guide for Clinicians.心力衰竭的利尿治疗:临床医生实用指南
J Clin Med. 2024 Jul 30;13(15):4470. doi: 10.3390/jcm13154470.
8
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold.药物发现中磺内酰胺的揭秘:聚焦未充分探索的骨架。
RSC Med Chem. 2024 Apr 16;15(6):1798-1827. doi: 10.1039/d3md00653k. eCollection 2024 Jun 19.
9
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data.与内皮素受体拮抗剂相关的肝损伤:一项基于美国食品药品监督管理局不良事件报告系统数据的药物警戒研究。
Int J Clin Pharm. 2024 Dec;46(6):1307-1316. doi: 10.1007/s11096-024-01757-3. Epub 2024 Jun 20.
10
Impact of Sulfonamide Allergy Label on Clinical Outcomes in Patients with Pneumocystis jirovecii Pneumonia.磺胺类药物过敏标签对耶氏肺孢子菌肺炎患者临床结局的影响。
Pulm Ther. 2024 Jun;10(2):225-236. doi: 10.1007/s41030-024-00260-4. Epub 2024 May 24.